• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特发性肺纤维化患者体重减轻的临床意义。

The Clinical Significance of Body Weight Loss in Idiopathic Pulmonary Fibrosis Patients.

机构信息

Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Royal Brompton Hospital, London, United Kingdom.

出版信息

Respiration. 2018;96(4):338-347. doi: 10.1159/000490355. Epub 2018 Aug 21.

DOI:10.1159/000490355
PMID:30130749
Abstract

BACKGROUND

The significance of the nutritional status in idiopathic pulmonary fibrosis (IPF) is largely unknown. Temporal body weight (BW) change, a dynamic index of nutrition status, can detect the malnutrition more accurately than the conventional single-point body mass index evaluation.

OBJECTIVE

To investigate how the temporal BW change influences the clinical courses of IPF.

METHODS

This multicenter study enrolled IPF patients from four referral hospitals of interstitial lung diseases in Japan (the Japanese cohort, the derivation cohort) and the Royal Brompton Hospital (the UK cohort, the validation cohort). The annual rate of BW change from the initial presentation was evaluated. A > 5% decrease of BW was defined as a significant BW loss.

RESULTS

Twenty-seven out of 124 patients in the Japanese cohort and 13 out of 86 patients in the UK cohort showed significant BW loss. Patients with BW loss showed significantly worse survival in both cohorts. Multivariate analyses revealed that BW loss was an independent factor for decreased survival (Japanese cohort: p = 0.047, UK cohort: p = 0.013). A 6.1% loss of BW was chosen as the optimal cutoff value to predict the 2-year mortality from the initial presentation. The stratified analysis revealed that a 6.1% or greater BW loss could predict worse survival specifically in cases without a greater than 10% decline in forced vital capacity (FVC).

CONCLUSIONS

BW loss is independently associated with the survival of IPF patients, particularly when a decline in the FVC was not observed. Further studies are needed to understand the mechanisms underlying BW loss in IPF.

摘要

背景

特发性肺纤维化(IPF)患者的营养状况意义重大,但目前尚不完全清楚。体重的时间变化(动态营养指标)比传统的单点体重指数评估更能准确检测营养不良。

目的

探讨体重的时间变化如何影响 IPF 的临床病程。

方法

本多中心研究纳入了来自日本四家间质性肺疾病转诊医院的 IPF 患者(日本队列,即推导队列)和英国皇家布朗普顿医院的患者(英国队列,即验证队列)。评估了从初始就诊到现在的体重年度变化率。体重下降>5%定义为明显体重下降。

结果

日本队列的 124 例患者中有 27 例和英国队列的 86 例患者中有 13 例出现明显的体重下降。体重下降的患者在两个队列中的生存率均显著降低。多变量分析显示,体重下降是生存率下降的独立因素(日本队列:p=0.047,英国队列:p=0.013)。体重下降 6.1%被选为预测从初始就诊到 2 年死亡率的最佳截断值。分层分析显示,体重下降 6.1%或更大可预测在用力肺活量(FVC)无下降 10%以上的情况下生存率更差。

结论

体重下降与 IPF 患者的生存率独立相关,尤其是在 FVC 无下降的情况下。需要进一步研究以了解 IPF 中体重下降的潜在机制。

相似文献

1
The Clinical Significance of Body Weight Loss in Idiopathic Pulmonary Fibrosis Patients.特发性肺纤维化患者体重减轻的临床意义。
Respiration. 2018;96(4):338-347. doi: 10.1159/000490355. Epub 2018 Aug 21.
2
Serial 6-month change in forced vital capacity predicts subsequent decline and mortality in Japanese patients with newly diagnosed idiopathic pulmonary fibrosis.新诊断特发性肺纤维化日本患者用力肺活量的 6 个月连续变化可预测随后的下降和死亡率。
Respir Investig. 2021 May;59(3):335-341. doi: 10.1016/j.resinv.2020.12.008. Epub 2021 Feb 4.
3
Change in forced vital capacity and associated subsequent outcomes in patients with newly diagnosed idiopathic pulmonary fibrosis.新诊断的特发性肺纤维化患者用力肺活量的变化及相关后续结局
BMC Pulm Med. 2015 Dec 29;15:167. doi: 10.1186/s12890-015-0161-5.
4
Predicting Outcomes in Idiopathic Pulmonary Fibrosis Using Automated Computed Tomographic Analysis.使用自动化计算机断层扫描分析预测特发性肺纤维化的结果。
Am J Respir Crit Care Med. 2018 Sep 15;198(6):767-776. doi: 10.1164/rccm.201711-2174OC.
5
Multi-dimensional Assessment of IPF Across a Wide Range of Disease Severity.特发性肺纤维化疾病严重度范围的多维评估。
Lung. 2018 Dec;196(6):707-713. doi: 10.1007/s00408-018-0152-4. Epub 2018 Aug 27.
6
Marginal decline in forced vital capacity is associated with a poor outcome in idiopathic pulmonary fibrosis.用力肺活量呈边际下降与特发性肺纤维化的不良预后相关。
Eur Respir J. 2010 Apr;35(4):830-6. doi: 10.1183/09031936.00155108. Epub 2009 Oct 19.
7
Negative impact of anorexia and weight loss during prior pirfenidone administration on subsequent nintedanib treatment in patients with idiopathic pulmonary fibrosis.既往服用吡非尼酮时出现厌食和体重减轻对特发性肺纤维化患者后续尼达尼布治疗的负面影响。
BMC Pulm Med. 2019 Apr 11;19(1):78. doi: 10.1186/s12890-019-0841-7.
8
Pulmonary hypertension as a prognostic indicator at the initial evaluation in idiopathic pulmonary fibrosis.特发性肺纤维化初始评估中肺动脉高压作为预后指标。
Respiration. 2013;85(6):456-63. doi: 10.1159/000345221. Epub 2012 Dec 19.
9
Association of hospital admission and forced vital capacity endpoints with survival in patients with idiopathic pulmonary fibrosis: analysis of a pooled cohort from three clinical trials.特发性肺纤维化患者住院和用力肺活量终点与生存的相关性:三项临床试验汇总队列分析。
Lancet Respir Med. 2015 May;3(5):388-96. doi: 10.1016/S2213-2600(15)00093-4. Epub 2015 Apr 15.
10
Characteristics and association with survival of respiratory-related hospitalization in Japanese idiopathic pulmonary fibrosis patients.日本特发性肺纤维化患者呼吸相关住院的特征及其与生存的关联
Respir Investig. 2019 Sep;57(5):415-421. doi: 10.1016/j.resinv.2019.03.005. Epub 2019 Apr 16.

引用本文的文献

1
The Relationship Between Chest Wall Muscle Thickness, Pulmonary Function, and Prognostic Markers in Idiopathic Pulmonary Fibrosis.特发性肺纤维化中胸壁肌肉厚度、肺功能和预后标志物之间的关系
Medicina (Kaunas). 2025 Jun 29;61(7):1181. doi: 10.3390/medicina61071181.
2
Malnutrition, Sarcopenia, and Malnutrition Sarcopenia Syndrome in Idiopathic Pulmonary Fibrosis.特发性肺纤维化中的营养不良、肌少症及营养不良肌少症综合征
Adv Respir Med. 2025 May 29;93(3):11. doi: 10.3390/arm93030011.
3
Mini nutritional assessment short-form as a risk factor for mortality in patients with respiratory disease undergoing urgent hospitalization.
简易营养评估量表简表作为呼吸系统疾病急诊住院患者死亡的危险因素。
BMC Geriatr. 2025 Feb 19;25(1):113. doi: 10.1186/s12877-025-05767-2.
4
Rectus femoris cross sectional area and timed up and go test potential useful of as a predictor of sarcopenia and mortality in idiopathic pulmonary fibrosis.股直肌横截面积及计时起立行走测试可能有助于预测特发性肺纤维化患者的肌肉减少症和死亡率。
Front Nutr. 2024 Dec 4;11:1440402. doi: 10.3389/fnut.2024.1440402. eCollection 2024.
5
Sarcopenia in interstitial lung disease.间质性肺疾病中的肌肉减少症
Eur Respir Rev. 2024 Dec 4;33(174). doi: 10.1183/16000617.0126-2024. Print 2024 Oct.
6
Antifibrotic drug treatment of patients with idiopathic pulmonary fibrosis in Sweden: A registry-based observational study.瑞典特发性肺纤维化患者的抗纤维化药物治疗:基于登记的观察性研究。
Chron Respir Dis. 2024 Jan-Dec;21:14799731241299443. doi: 10.1177/14799731241299443.
7
Patient-centered care in pulmonary fibrosis: access, anticipate, and act.肺纤维化中的以患者为中心的护理:获得、预见和行动。
Respir Res. 2024 Nov 1;25(1):395. doi: 10.1186/s12931-024-02997-7.
8
Automated 3D-Body Composition Analysis as a Predictor of Survival in Patients With Idiopathic Pulmonary Fibrosis.自动三维身体成分分析作为特发性肺纤维化患者生存的预测指标
J Thorac Imaging. 2025 Mar 1;40(2):e0803. doi: 10.1097/RTI.0000000000000803.
9
Higher body mass index was associated with a lower mortality of idiopathic pulmonary fibrosis: a meta-analysis.较高的身体质量指数与特发性肺纤维化的死亡率降低相关:一项荟萃分析。
J Health Popul Nutr. 2024 Aug 16;43(1):124. doi: 10.1186/s41043-024-00620-5.
10
Malnutrition is associated with mortality in Sjögren's syndrome-associated interstitial lung disease.营养不良与干燥综合征相关间质性肺疾病的死亡率相关。
Sci Rep. 2024 Aug 1;14(1):17842. doi: 10.1038/s41598-024-68754-4.